New Approaches in Locoregional Therapies for Hepatocellular Carcinoma.

Date publication

septembre 2016

Journal

Journal of gastrointestinal cancer

Auteurs

Membres identifiés du Cancéropôle Est :
Pr MARESCAUX Jacques , Pr PESSAUX Patrick , Pr MUTTER Didier

Tous les auteurs :
Memeo R, de Blasi V, Cherkaoui Z, Dehlawi A, De' Angelis N, Piardi T, Sommacale D, Marescaux J, Mutter D, Pessaux P

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/27270711

Résumé

Hepatocellular carcinoma (HCC) represent actually the fifth most common cancer worldwide, with liver transplantation and hepatic resection who represent the standard of care of curative treatment. Unfortunately, not all patient could benefit of curative treatment. For such patients, locoregional or systemic therapies represent a valid option in order to achieve the best survival possible.

Référence

J Gastrointest Cancer. 2016 Sep;47(3):239-46